Skip to content

COMPARISON OF GLYCOLIC ACID PEEL (50%) WITH LACTIC ACID PEEL (82%) IN MELASMA

Comparison of Glycolic acid peel (50%) with Lactic acid peel (82%) in Melasma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014417
Enrollment
10
Registered
2018-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- MELASMA

Interventions

Intervention1: GLYCOLIC ACID PEEL (50%) : ALL CLINICALLY DIAGNOSED MALE AND FEMALE PATIENTS OF BILATERAL FACIAL EPIDERMAL AND/OR MIXED MELASMA WAS TAKEN AND GLYCOLIC ACID PEEL (50%) WAS APPLIED OVER R

Sponsors

DR JASMINE KOHLI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH EPIDERMAL AND/OR MIXED BILATERAL FACIAL MELASMA AGE MORE THAN OR EQUAL TO 18 YEARS PATIENTS OF EITHER SEX HAVING BILATERAL FACIAL MELASMA PATIENT WILLING TO GIVE WRITTEN/ INFORMED CONSENT PATIENT WILLING FOR FOLLOW UP

Exclusion criteria

Exclusion criteria: PATIENTS WITH DERMAL AND/OR DEEP DERMAL FACIAL MELASMA AGE LESS THAN 18 YEARS ACTIVE BACTERIAL, VIRAL, FUNGAL OR HERPETIC ON THE AREA TO BE PEELED OPEN WOUNDS ON THE AREA TO BE PEELED RECENT HISTORY OF ( LESS THAN 1 MONTH ) DRUGS WITH PHOTOSENSITIZING POTENTIAL PRE EXISTING INFLAMMATORY DERMATOSIS AND SYSTEMIC ILLNESS HAVING PHOTOSENSITIZING POTENTIAL SUCH AS POLYMORPHIC LIGHT ERUPTION,ATOPIC DERMATITIS, PELLAGRA, PORPHYRIA ON THE AREA TO BE PEELED. PREGNANCY AND LACTATION AT PRESENT PATIENTS ON ORAL CONTRACEPTIVE PILLS. UNCOPERATIVE PATIENT. PATIENT WITH UNREALISTIC EXPECTATIONS PATIENT NOT WILLING TO GIVE CONSENT. PATIENT NOT COMING FOR REGULAR FOLLOW UP.

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE EFFICACY OF GLYCOLIC ACID PEEL (50%) WITH LACTIC ACID PEEL (82%) IN MELASMATimepoint: 2WEEKS,4WEEKS, 6 WEEKS, 8 WEEKS, 10 WEEKS

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR JASMINE KOHLI

SHRI RAM MURTI SMARAK INSTITUTE OF MEDICAL SCIENCES

dermanitin@gmail.com9012303662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026